This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Claudio M. Martin, MD; Anne G. Matlow, MD; Emily Chew, MD; David Sutton, MD; Waldemar Pruzanski, MD

Arch Intern Med. 1989;149(6):1435-1436.

Abstract
• The hyperviscosity syndrome is most commonly seen in association with monoclonal gammopathies and has only rarely been described in association with polyclonal hypergammaglobulinemia. We have recently seen a patient with known acquired immunodeficiency syndrome who presented with the hyperviscosity syndrome in the setting of polyclonal hypergammaglobulinemia. To our knowledge, this is the first reported case of a patient with the acquired immunodeficiency syndrome and the hyperviscosity syndrome. The case is presented and the pathogenesis and implications of this diagnosis are discussed.

(Arch Intern Med. 1989;149:1435-1436)

Author Affiliations
From the Departments of Medicine, The Wellesley Hospital, Toronto, Canada (Drs Martin, Matlow, and Pruzanski), and Toronto (Canada) Western Hospital (Dr Sutton), and the Department of Ophthalmology, National Institutes of Health, Bethesda, Md (Dr Chew).

Footnotes
Accepted for publication December 23, 1988.

Reprint requests to Department of Medicine, Room 425, The E. K. Jones Building, The Wellesley Hospital, 160 Wellesley St E, Toronto, Ontario, Canada M4Y 1J3 (Dr Matlow).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Averse Effects of Intravenous Immunoglobulin Therapy
Ryan et al.
CLIN PEDIATR 1996;35:23-31.